Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral...

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Cav3.2 T-type calcium channels are crucial for pain signaling.
• Upregulation of Cav3.2 channels, linked to deubiquitinase USP5, occurs during inflammation and neuropathy.
• Previous studies showed blocking USP5-Cav3.2 interaction reverses pain in male mice.

Purpose of the Study:

• To investigate the efficacy of blocking USP5 binding to Cav3.2 channels in female mice with induced pain.
• To determine if the therapeutic effect observed in males extends to females, exploring potential sex differences.

Main Methods:

• Female mice underwent synchronized estrous cycles and received Complete Freund's Adjuvant (CFA) to induce inflammation.
• Intrathecal administration of a cell-penetrating TAT peptide targeting the USP5 UBPc domain was used.
• Mechanical and thermal hypersensitivity were assessed before and after peptide treatment.

Main Results:

• Intrathecal delivery of the TAT peptide targeting USP5 fully reversed mechanical hypersensitivity in CFA-injected female mice.
• The observed reversal of pain hypersensitivity in females mirrors findings in male mice.
• These results indicate no significant sex-based difference in the therapeutic effect.

Conclusions:

• The interaction between USP5 and Cav3.2 channels contributes to pain hypersensitivity in a manner not dependent on sex.
• Therapeutic strategies targeting the USP5-Cav3.2 interaction show promise for treating pain in both male and female patients.
• This finding supports the development of novel analgesics targeting this specific molecular pathway.